Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-29 18:16:04 - browse：66

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Gene therapy has helped boys walk. Can scientists keep it that way?

WSS

Death of patient in Alzheimer’s trial raises question of possible risks

Gene therapy has helped boys walk. Can scientists keep it that way?

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Senate panel to vote on hospitals, PBMs, prisoner care

Do masks work? RCTs can't tell us

Wikipedia

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Supreme Court strikes down use of affirmative action

Medtronic CEO on promising devices for diabetes, hypertension

Cancer drug shortages should be causing more outrage

Colonoscopy at 40? Study finds a possible benefit

Psychedelics group wrestles with new pharma identity

Cassava reveals details — and problems — with Alzheimer's study

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

entertainment

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

WATCH: Why do fingernails fall off when they're damaged?

Paying for Covid pills will soon shift to insurers

New guidelines on severe brain injury complicate already difficult decisions

The strategy behind pharma's lawsuits over drug pricing reform

Colonoscopy at 40? Study finds a possible benefit

knowledge

hotspot

focus

explore